A novel approach for the synthesis of Crizotinib through the key chiral alcohol intermediate by asymmetric hydrogenation using highly active Ir-Spiro-PAP catalyst-Reference-Cited by-同舟云学术

A novel approach for the synthesis of Crizotinib through the key chiral alcohol intermediate by asymmetric hydrogenation using highly active Ir-Spiro-PAP catalyst

Published:2014-02 Issue:9 Volume:55 Page:1528-1531
ISSN:0040-4039
Container-title:Tetrahedron Letters
language:en
Short-container-title:Tetrahedron Letters

Author:

Qian Jian-Qiang,Yan Pu-Cha,Che Da-Qing,Zhou Qi-Lin,Li Yuan-Qiang

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Reference27 articles.

1. An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms

2. Cancer statistics, 2012

3. Responding to the Challenge of Cancer in Europe,2008

4. Crizotinib — Latest Champion in the Cancer Wars?

5. Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Manganese catalyzed asymmetric transfer hydrogenation of hindered ketones bearing a 2,6-disubstituted phenyl group;Journal of Catalysis;2024-10

2. Epinephrine, Pregabalin, and Crizotinib as Three Medicines with Polish Implications over Three Last Centuries and in View of Three Different Drug Discovery Approaches;Biomedicines;2024-09-04

3. Chiral P,N,N‐Ligands for Asymmetric Hydrogenation;Advanced Synthesis & Catalysis;2024-04-24

4. Design and synthesis of fluorine aromatic scaffolds containing drugs approved by the US FDA from 2002 to 2022;Results in Chemistry;2024-01

5. Novel Chiral Tridentate PNN Ligand Manganese Complex for Enantioselective Hydrogenation of Aromatic Ketones;Acta Chimica Sinica;2024